Growth Metrics

Surgery Partners (SGRY) Long-Term Deferred Tax (2016 - 2024)

Surgery Partners (SGRY) has disclosed Long-Term Deferred Tax for 10 consecutive years, with $79.2 million as the latest value for Q3 2024.

  • Quarterly Long-Term Deferred Tax fell 24.57% to $79.2 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $79.2 million through Sep 2024, down 24.57% year-over-year, with the annual reading at $89.5 million for FY2023, 2.19% down from the prior year.
  • Long-Term Deferred Tax hit $79.2 million in Q3 2024 for Surgery Partners, down from $81.8 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $129.8 million in Q2 2021 to a low of $79.2 million in Q3 2024.
  • Historically, Long-Term Deferred Tax has averaged $106.3 million across 5 years, with a median of $105.7 million in 2023.
  • Biggest five-year swings in Long-Term Deferred Tax: rose 26.44% in 2020 and later decreased 24.57% in 2024.
  • Year by year, Long-Term Deferred Tax stood at $124.8 million in 2020, then fell by 8.33% to $114.4 million in 2021, then decreased by 20.02% to $91.5 million in 2022, then decreased by 2.19% to $89.5 million in 2023, then dropped by 11.51% to $79.2 million in 2024.
  • Business Quant data shows Long-Term Deferred Tax for SGRY at $79.2 million in Q3 2024, $81.8 million in Q2 2024, and $87.0 million in Q1 2024.